NanoSphere Health Sciences Secures Patent for Nanoparticle Delivery of Cannabis

Biotech leader now owns first and only cannabis nanoparticle delivery system in North America

NanoSphere Health Sciences LLC (CSE: NSHS) (OTC: NSHSF) has been awarded a breakthrough patent, granting the biotech innovator full ownership over the standardized delivery of cannabis into systemic circulation through phospholipid nanoparticle technology. The United States Patent and Trademark Office has issued US Patent No. 10,028,919 today, covering NanoSphere Health Sciences’ cannabinoid drug delivery system.

The cannabinoid drug delivery system utilizes the research-proven NanoSphere Delivery System™, providing delivery of cannabinoids through a unique lipid nanoparticle structure with increased bioavailability and therapeutic activity. NanoSphere’s groundbreaking cannabinoid drug delivery system nanoencapsulates cannabinoids in a protective membrane, transporting them rapidly and effectively to the bloodstream and cells for greater efficacy. This delivery platform, which was recently awarded the Frost and Sullivan 2018 Best Practices Award for Technological Innovation, makes the nanoencapsulated cannabinoids safer, more bioavailable and faster-acting, while also reducing adverse effects by delivering precise doses of cannabinoids in smart nanoparticles to target sites.

You can learn more here:

Comments